Abstract
The rapid emergence of drug-resistant bacteria and the lack of new antibiotics entering the market is a major worldwide concern. Antimicrobial peptides (AMPs) are deemed plausible drug candidates as they specifically target and disrupt microbial cell membranes, causing death by cell lysis. However, their instability towards plasma proteases and perceived high manufacturing cost limit their potential for further drug development. A plausible solution is to identify and develop very short linear peptides as topical agents for treating skin and soft tissue infections. A literature survey yielded 30 ultra-short AMPs up to 9 residues in length with antimicrobial activities. They were commercially synthesized and a head-to-head antimicrobial activity comparison was conducted on common skin pathogens including meticillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans. The topical broad-spectrum antibiotic Gentamicin and antifungal Nystatin were included as controls. Experimental results revealed only 2 peptides with potent broad-spectrum activities; octapeptide IRIRIRIR-NH2 and nonapeptide Ac-KWRRWVRWI-NH2 exhibited MICs of 6.25 μM against all test microbes. Both peptides have been reported to be non-cytotoxic to human cells, suggesting that they could potentially be further developed as topical antimicrobial agents.
References
Abbassi F, Lequin O, Piesse C, Goasdoué N, Foulon T, Nicolas T et al (2010) Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide. J Biol Chem 285:16880–16892
Andersson DI, Hughes D (2014) Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol 12:465–478
Athar MA, Winner HI (1971) Development of resistance by Candida species to polyene antibiotics in vitro. J Med Microbiol 4:505–517
Bassetti M, Merelli M, Temperoni C, Astilean A (2013) New antibiotics for bad bugs: where are we? Ann Clin Microbiol Antimicrob 12:22
Bisht GS, Rawat DS, Kumar A, Kumar R, Pasha S (2007) Antimicrobial activity of rationally designed amino terminal modified peptides. Bioorg Med Chem Lett 17:4343–4346
Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB et al (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1–12
Brogden NK, Brogden KA (2011) Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int J Antimicrob Agents 38:217–225
Catiau L, Traisnel J, Delval-Dubois V, Chihib N, Guillochon D, Nedjar-Arroume N (2011a) Minimal antimicrobial peptidic sequence from hemoglobin alpha-chain: KYR. Peptides 32:633–638
Catiau L, Traisnel J, Chihib N, Le Flem G, Blanpain A, Melnyk O et al (2011b) RYH: A minimal peptidic sequence obtained from beta-chain hemoglobin exhibiting an antimicrobial activity. Peptides 32:1463–1468
Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. Document M100-S16. CLSI, Wayne
Cutuli M, Cristiani S, Lipton JM, Catania A (2000) Antimicrobial effects of α-MSH peptides. J Leukoc Biol 67:233–239
Dryden MS (2010) Complicated skin and soft tissue infection. J Antimicrob Chemother 65(Suppl 3): iii35–44
Fimland G, Eijsink VG, Nissen-Meyer J (2002) Mutational analysis of the role of tryptophan residues in an antimicrobial peptide. Biochemistry 41:9508–9515
Fjell CD, Hiss JA, Hancock REW, Schneider G (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11:37–51
Gopal R, Kim YJ, Seo CH, Hahm KS, Park Y (2011) Reversed sequence enhances antimicrobial activity of a synthetic peptide. J Pept Sci 17:329–334
Guzmán F, Marshall S, Ojeda C, Albericio F, Carvajal-Rondanelli P (2013) Inhibitory effect of short cationic homopeptides against Gram-positive bacteria. J Pept Sci 19:792–800
Hancock REW (2000) Cationic antimicrobial peptides: towards clinical applications. Exp Opin Invest Drugs 9:1723–1729
Hancock REW, Sahl H (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24:1551–1557
Hilpert K, Volkmer-Engert R, Walter T, Hancock REW (2005) High-throughput generation of small antibacterial peptides with improved activity. Nat Biotechnol 23:1008–1012
Hilpert K, Elliott M, Jenssen H, Kindrachuk J, Fjell CD, Körner J et al (2009) Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. Chem Biol 16:58–69
Hitchcock CA, Barrett-Bee KJ, Russell NJ (1987) The lipid composition and permeability to azole of an azole- and polyene-resistant mutant of Candida albicans. J Med Vet Mycol 25:29–37
King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM (2006) Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 144:309–317
Liakopoulou-Kyriakides M, Pachatouridis C, Ekateriniadou L, Papageorgiou VP (1997) A new synthesis of the tripeptide Gly-His-Lys with antimicrobial activity. Amino Acids 13:155–161
Limbago B, Fosheim GE, Schoonover V, Crane CE, Nadle J, Petit S et al (2009) Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol 47:1344–1351
Liu Z, Brady A, Young A, Rasimick B, Chen K, Zhou C et al (2007) Length effects in antimicrobial peptides of the (RW)n series. Antimicrob Agents Chemother 51:597–603
Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB et al (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355:666–674
Murugan RN, Jacob B, Kim EH, Ahn M, Sohn H, Seo JH et al (2013) Non hemolytic short peptidomimetics as a new class of potent and broad-spectrum antimicrobial agents. Bioorg Med Chem Lett 23:4633–4636
Nagarajan K, Senthamarai R, Devi K, Deepa SS, Anandh N, Krishnaveni P et al (2008) Assessment of antimicrobial activity for the smaller chain dipeptides and tripeptides. J Cell Tissue Res 8:1265–1269
Naidoo VB, Rautenbach M (2013) Self-assembling organo-peptide bolaphiles with KLK tripeptide head groups display selective antibacterial activity. J Pept Sci 19:784–791
Ong ZY, Gao SJ, Yang YY (2013) Short synthetic β-sheet forming peptide amphiphiles as broad spectrum antimicrobials with antibiofilm and endotoxin neutralizing capabilities. Adv Funct Mater 23:3682–3692
Pérez-Vázquez M, Vindel A, Marcos C, Oteo J, Cuevas O, Trincado P et al (2009) Spread of invasive Spanish Staphylococcus aureus spa-type t067 associated with a high prevalence of the aminoglycoside-modifying enzyme gene ant(4′)-Ia and the efflux pump genes msrA/msrB. J Antimicrob Chemother 63:21–31
Qi X, Zhou C, Li P, Xu W, Cao Y, Ling H et al (2010) Novel short antibacterial and antifungal peptides with low cytotoxicity: efficacy and action mechanisms. Biochem Biophys Res Commun 398:594–600
Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M et al (2013) Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides. Antimicrob Agents Chemother 57:2295–2303
Rathinakumar R, Walkenhorst WF, Wimley WC (2009) Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. J Am Chem Soc 131:7609–7617
Romanelli A, Moggio L, Montella RC, Campiglia P, Iannaccone M, Capuano F et al (2011) Peptides from royal jelly: studies on the antimicrobial activity of jelleins, jelleins analogs and synergy with temporins. J Pept Sci 17:348–352
Sader HS, Fedler KA, Rennie RP, Stevens S, Jones RN (2004) Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity. Antimicrob Agents Chemother 48:3112–3118
Schmitz FJ, Fluit AC, Gondolf M, Beyrau R, Lindenlauf E, Verhoef J et al (1999) The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. J Antimicrob Chemother 43:253–259
Segal E (2005) Candida, still number one—what do we know and where are we going from there? Mycoses 48(Suppl. 1):3–11
Selby NM, Shaw S, Woodier N, Fluck RJ, Kolhe NV (2009) Gentamicin-associated acute kidney injury. QJM 102:873–880
Shin S, Kim JK, Lee JY, Jung KW, Hwang JS, Lee J et al (2009) Design of potent 9-mer antimicrobial peptide analogs of protaetiamycine and investigation of mechanism of antimicrobial action. J Pept Sci 15:559–568
Shooshtarizadeh P, Zhang D, Chich J, Gasnier C, Schneider F, Haïkel Y et al (2010) The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity. Regul Pept 165:102–110
Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM et al (2008) The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 46:155–164
Strøm MB, Rekdal Ø, Svendsen JS (2002) Antimicrobial activity of short arginine- and tryptophan-rich peptides. J Pept Sci 8:431–437
Strøm MB, Haug BF, Skar ML, Stensen W, Stiberg T, Svendsen JS (2003) The pharmacophore of short cationic antibacterial peptides. J Med Chem 46:1567–1570
Wei SY, Wu JM, Kuo YY, Chen HL, Yip BS, Tzeng SR et al (2006) Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity. J Bacteriol 188:328–334
Wimley WC (2010) Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem Biol 5:905–917
Yeung ATY, Gellatly SL, Hancock REW (2011) Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci 68:2161–2176
Zanetti M (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75:39–48
Zorko M, Japelj B, Hafner-Bratkovič I, Jerala R (2009) Expression, purification and structural studies of a short antimicrobial peptide. Biochim Biophys Acta 1788:314–323
Acknowledgments
We thank A*STAR Biomedical Research Council for financial support.
Conflict of Interest
Qiu Ying Lau, Xing Yao Choo, Zhi Xue Lim, Xin Ni Kong, Fui Mee Ng, Melgious J. Y. Ang, Jeffrey Hill and C. S. Brian Chia declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies involving human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
Xing Yao Choo, Zhi Xue Lim, and Xin Ni Kong have contributed equally in this work.
Rights and permissions
About this article
Cite this article
Lau, Q.Y., Choo, X.Y., Lim, Z.X. et al. A Head-to-Head Comparison of the Antimicrobial Activities of 30 Ultra-Short Antimicrobial Peptides Against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans . Int J Pept Res Ther 21, 21–28 (2015). https://doi.org/10.1007/s10989-014-9440-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10989-014-9440-x